nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.00321	0.00321	CcSEcCtD
Budesonide—Nervous system disorder—Vincristine—muscle cancer	0.00321	0.00321	CcSEcCtD
Budesonide—Decreased appetite—Dactinomycin—muscle cancer	0.00318	0.00318	CcSEcCtD
Budesonide—Dysgeusia—Etoposide—muscle cancer	0.00318	0.00318	CcSEcCtD
Budesonide—Hyperhidrosis—Vincristine—muscle cancer	0.00316	0.00316	CcSEcCtD
Budesonide—Fatigue—Dactinomycin—muscle cancer	0.00316	0.00316	CcSEcCtD
Budesonide—Back pain—Etoposide—muscle cancer	0.00314	0.00314	CcSEcCtD
Budesonide—Pain—Dactinomycin—muscle cancer	0.00313	0.00313	CcSEcCtD
Budesonide—Vascular purpura—Doxorubicin—muscle cancer	0.00312	0.00312	CcSEcCtD
Budesonide—Muscle spasms—Etoposide—muscle cancer	0.00312	0.00312	CcSEcCtD
Budesonide—Anorexia—Vincristine—muscle cancer	0.00312	0.00312	CcSEcCtD
Budesonide—Eczema—Doxorubicin—muscle cancer	0.00311	0.00311	CcSEcCtD
Budesonide—Irritability—Methotrexate—muscle cancer	0.00308	0.00308	CcSEcCtD
Budesonide—Mood swings—Methotrexate—muscle cancer	0.00306	0.00306	CcSEcCtD
Budesonide—Feeling abnormal—Dactinomycin—muscle cancer	0.00302	0.00302	CcSEcCtD
Budesonide—Ill-defined disorder—Etoposide—muscle cancer	0.00301	0.00301	CcSEcCtD
Budesonide—Anaemia—Etoposide—muscle cancer	0.003	0.003	CcSEcCtD
Budesonide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00299	0.00299	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00298	0.00298	CcSEcCtD
Budesonide—Increased appetite—Doxorubicin—muscle cancer	0.00297	0.00297	CcSEcCtD
Budesonide—Insomnia—Vincristine—muscle cancer	0.00296	0.00296	CcSEcCtD
Budesonide—Paraesthesia—Vincristine—muscle cancer	0.00294	0.00294	CcSEcCtD
Budesonide—Malaise—Etoposide—muscle cancer	0.00293	0.00293	CcSEcCtD
Budesonide—Breast disorder—Methotrexate—muscle cancer	0.00292	0.00292	CcSEcCtD
Budesonide—Vertigo—Etoposide—muscle cancer	0.00292	0.00292	CcSEcCtD
Budesonide—Purpura—Doxorubicin—muscle cancer	0.0029	0.0029	CcSEcCtD
Budesonide—Body temperature increased—Dactinomycin—muscle cancer	0.00289	0.00289	CcSEcCtD
Budesonide—Abdominal pain—Dactinomycin—muscle cancer	0.00289	0.00289	CcSEcCtD
Budesonide—Loss of consciousness—Etoposide—muscle cancer	0.00285	0.00285	CcSEcCtD
Budesonide—Decreased appetite—Vincristine—muscle cancer	0.00284	0.00284	CcSEcCtD
Budesonide—Cough—Etoposide—muscle cancer	0.00283	0.00283	CcSEcCtD
Budesonide—Gastrointestinal disorder—Vincristine—muscle cancer	0.00282	0.00282	CcSEcCtD
Budesonide—Fatigue—Vincristine—muscle cancer	0.00282	0.00282	CcSEcCtD
Budesonide—Hypertension—Etoposide—muscle cancer	0.0028	0.0028	CcSEcCtD
Budesonide—Pain—Vincristine—muscle cancer	0.0028	0.0028	CcSEcCtD
Budesonide—Constipation—Vincristine—muscle cancer	0.0028	0.0028	CcSEcCtD
Budesonide—Chest pain—Etoposide—muscle cancer	0.00276	0.00276	CcSEcCtD
Budesonide—Migraine—Doxorubicin—muscle cancer	0.00275	0.00275	CcSEcCtD
Budesonide—Affect lability—Doxorubicin—muscle cancer	0.00275	0.00275	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00274	0.00274	CcSEcCtD
Budesonide—Discomfort—Etoposide—muscle cancer	0.00273	0.00273	CcSEcCtD
Budesonide—Face oedema—Doxorubicin—muscle cancer	0.0027	0.0027	CcSEcCtD
Budesonide—Hypersensitivity—Dactinomycin—muscle cancer	0.0027	0.0027	CcSEcCtD
Budesonide—Gastrointestinal pain—Vincristine—muscle cancer	0.00267	0.00267	CcSEcCtD
Budesonide—Confusional state—Etoposide—muscle cancer	0.00267	0.00267	CcSEcCtD
Budesonide—Anaphylactic shock—Etoposide—muscle cancer	0.00265	0.00265	CcSEcCtD
Budesonide—Mood swings—Doxorubicin—muscle cancer	0.00265	0.00265	CcSEcCtD
Budesonide—Infection—Etoposide—muscle cancer	0.00263	0.00263	CcSEcCtD
Budesonide—Asthenia—Dactinomycin—muscle cancer	0.00263	0.00263	CcSEcCtD
Budesonide—Dysuria—Methotrexate—muscle cancer	0.00261	0.00261	CcSEcCtD
Budesonide—Tachycardia—Etoposide—muscle cancer	0.00259	0.00259	CcSEcCtD
Budesonide—Abdominal pain—Vincristine—muscle cancer	0.00258	0.00258	CcSEcCtD
Budesonide—Body temperature increased—Vincristine—muscle cancer	0.00258	0.00258	CcSEcCtD
Budesonide—Skin disorder—Etoposide—muscle cancer	0.00257	0.00257	CcSEcCtD
Budesonide—Hyperhidrosis—Etoposide—muscle cancer	0.00256	0.00256	CcSEcCtD
Budesonide—Abdominal pain upper—Doxorubicin—muscle cancer	0.00255	0.00255	CcSEcCtD
Budesonide—Hypokalaemia—Doxorubicin—muscle cancer	0.00254	0.00254	CcSEcCtD
Budesonide—Breast disorder—Doxorubicin—muscle cancer	0.00253	0.00253	CcSEcCtD
Budesonide—Anorexia—Etoposide—muscle cancer	0.00252	0.00252	CcSEcCtD
Budesonide—Diarrhoea—Dactinomycin—muscle cancer	0.0025	0.0025	CcSEcCtD
Budesonide—Nasopharyngitis—Doxorubicin—muscle cancer	0.0025	0.0025	CcSEcCtD
Budesonide—Infestation—Methotrexate—muscle cancer	0.00249	0.00249	CcSEcCtD
Budesonide—Infestation NOS—Methotrexate—muscle cancer	0.00249	0.00249	CcSEcCtD
Budesonide—Abdominal distension—Doxorubicin—muscle cancer	0.00243	0.00243	CcSEcCtD
Budesonide—Conjunctivitis—Methotrexate—muscle cancer	0.00242	0.00242	CcSEcCtD
Budesonide—Influenza—Doxorubicin—muscle cancer	0.00242	0.00242	CcSEcCtD
Budesonide—Hypersensitivity—Vincristine—muscle cancer	0.00241	0.00241	CcSEcCtD
Budesonide—Paraesthesia—Etoposide—muscle cancer	0.00238	0.00238	CcSEcCtD
Budesonide—Haematuria—Methotrexate—muscle cancer	0.00237	0.00237	CcSEcCtD
Budesonide—Dyspnoea—Etoposide—muscle cancer	0.00236	0.00236	CcSEcCtD
Budesonide—Somnolence—Etoposide—muscle cancer	0.00235	0.00235	CcSEcCtD
Budesonide—Epistaxis—Methotrexate—muscle cancer	0.00235	0.00235	CcSEcCtD
Budesonide—Asthenia—Vincristine—muscle cancer	0.00235	0.00235	CcSEcCtD
Budesonide—Vomiting—Dactinomycin—muscle cancer	0.00233	0.00233	CcSEcCtD
Budesonide—Bronchitis—Doxorubicin—muscle cancer	0.00232	0.00232	CcSEcCtD
Budesonide—Rash—Dactinomycin—muscle cancer	0.00231	0.00231	CcSEcCtD
Budesonide—Decreased appetite—Etoposide—muscle cancer	0.0023	0.0023	CcSEcCtD
Budesonide—Gastrointestinal disorder—Etoposide—muscle cancer	0.00229	0.00229	CcSEcCtD
Budesonide—Fatigue—Etoposide—muscle cancer	0.00228	0.00228	CcSEcCtD
Budesonide—Pain—Etoposide—muscle cancer	0.00226	0.00226	CcSEcCtD
Budesonide—Constipation—Etoposide—muscle cancer	0.00226	0.00226	CcSEcCtD
Budesonide—Dysuria—Doxorubicin—muscle cancer	0.00226	0.00226	CcSEcCtD
Budesonide—Haemoglobin—Methotrexate—muscle cancer	0.00224	0.00224	CcSEcCtD
Budesonide—Diarrhoea—Vincristine—muscle cancer	0.00224	0.00224	CcSEcCtD
Budesonide—Haemorrhage—Methotrexate—muscle cancer	0.00223	0.00223	CcSEcCtD
Budesonide—Pollakiuria—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Budesonide—Pharyngitis—Methotrexate—muscle cancer	0.00222	0.00222	CcSEcCtD
Budesonide—Urinary tract disorder—Methotrexate—muscle cancer	0.00221	0.00221	CcSEcCtD
Budesonide—Weight increased—Doxorubicin—muscle cancer	0.0022	0.0022	CcSEcCtD
Budesonide—Urethral disorder—Methotrexate—muscle cancer	0.00219	0.00219	CcSEcCtD
Budesonide—Feeling abnormal—Etoposide—muscle cancer	0.00218	0.00218	CcSEcCtD
Budesonide—Nausea—Dactinomycin—muscle cancer	0.00217	0.00217	CcSEcCtD
Budesonide—Gastrointestinal pain—Etoposide—muscle cancer	0.00217	0.00217	CcSEcCtD
Budesonide—Dizziness—Vincristine—muscle cancer	0.00216	0.00216	CcSEcCtD
Budesonide—Infestation—Doxorubicin—muscle cancer	0.00215	0.00215	CcSEcCtD
Budesonide—Infestation NOS—Doxorubicin—muscle cancer	0.00215	0.00215	CcSEcCtD
Budesonide—Visual impairment—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Budesonide—Urticaria—Etoposide—muscle cancer	0.0021	0.0021	CcSEcCtD
Budesonide—Abdominal pain—Etoposide—muscle cancer	0.00209	0.00209	CcSEcCtD
Budesonide—Body temperature increased—Etoposide—muscle cancer	0.00209	0.00209	CcSEcCtD
Budesonide—Urinary tract infection—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Budesonide—Conjunctivitis—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Budesonide—Eye disorder—Methotrexate—muscle cancer	0.00209	0.00209	CcSEcCtD
Budesonide—Vomiting—Vincristine—muscle cancer	0.00208	0.00208	CcSEcCtD
Budesonide—Cardiac disorder—Methotrexate—muscle cancer	0.00207	0.00207	CcSEcCtD
Budesonide—Rash—Vincristine—muscle cancer	0.00206	0.00206	CcSEcCtD
Budesonide—Dermatitis—Vincristine—muscle cancer	0.00206	0.00206	CcSEcCtD
Budesonide—Haematuria—Doxorubicin—muscle cancer	0.00205	0.00205	CcSEcCtD
Budesonide—Headache—Vincristine—muscle cancer	0.00205	0.00205	CcSEcCtD
Budesonide—Epistaxis—Doxorubicin—muscle cancer	0.00203	0.00203	CcSEcCtD
Budesonide—Angiopathy—Methotrexate—muscle cancer	0.00203	0.00203	CcSEcCtD
Budesonide—Sinusitis—Doxorubicin—muscle cancer	0.00202	0.00202	CcSEcCtD
Budesonide—Immune system disorder—Methotrexate—muscle cancer	0.00202	0.00202	CcSEcCtD
Budesonide—Mediastinal disorder—Methotrexate—muscle cancer	0.00201	0.00201	CcSEcCtD
Budesonide—Alopecia—Methotrexate—muscle cancer	0.00197	0.00197	CcSEcCtD
Budesonide—Mental disorder—Methotrexate—muscle cancer	0.00196	0.00196	CcSEcCtD
Budesonide—Hypersensitivity—Etoposide—muscle cancer	0.00195	0.00195	CcSEcCtD
Budesonide—Malnutrition—Methotrexate—muscle cancer	0.00194	0.00194	CcSEcCtD
Budesonide—Haemoglobin—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
Budesonide—Nausea—Vincristine—muscle cancer	0.00194	0.00194	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
Budesonide—Haemorrhage—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Budesonide—Pharyngitis—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Budesonide—Urinary tract disorder—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Budesonide—Oedema peripheral—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Budesonide—Dysgeusia—Methotrexate—muscle cancer	0.0019	0.0019	CcSEcCtD
Budesonide—Asthenia—Etoposide—muscle cancer	0.0019	0.0019	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Budesonide—Back pain—Methotrexate—muscle cancer	0.00188	0.00188	CcSEcCtD
Budesonide—Pruritus—Etoposide—muscle cancer	0.00187	0.00187	CcSEcCtD
Budesonide—Visual impairment—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Budesonide—Vision blurred—Methotrexate—muscle cancer	0.00183	0.00183	CcSEcCtD
Budesonide—Diarrhoea—Etoposide—muscle cancer	0.00181	0.00181	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Budesonide—Ill-defined disorder—Methotrexate—muscle cancer	0.0018	0.0018	CcSEcCtD
Budesonide—Anaemia—Methotrexate—muscle cancer	0.0018	0.0018	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Budesonide—Flushing—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Budesonide—Malaise—Methotrexate—muscle cancer	0.00175	0.00175	CcSEcCtD
Budesonide—Dizziness—Etoposide—muscle cancer	0.00175	0.00175	CcSEcCtD
Budesonide—Immune system disorder—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Budesonide—Vertigo—Methotrexate—muscle cancer	0.00175	0.00175	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Budesonide—Cough—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Budesonide—Vomiting—Etoposide—muscle cancer	0.00168	0.00168	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Budesonide—Rash—Etoposide—muscle cancer	0.00167	0.00167	CcSEcCtD
Budesonide—Dermatitis—Etoposide—muscle cancer	0.00167	0.00167	CcSEcCtD
Budesonide—Headache—Etoposide—muscle cancer	0.00166	0.00166	CcSEcCtD
Budesonide—Flatulence—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Budesonide—Chest pain—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Budesonide—Arthralgia—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Budesonide—Myalgia—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Budesonide—Tension—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Budesonide—Discomfort—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—muscle cancer	0.00163	0.00163	CcSEcCtD
Budesonide—Back pain—Doxorubicin—muscle cancer	0.00163	0.00163	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Budesonide—Confusional state—Methotrexate—muscle cancer	0.0016	0.0016	CcSEcCtD
Budesonide—Anaphylactic shock—Methotrexate—muscle cancer	0.00159	0.00159	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Budesonide—Infection—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Budesonide—Nausea—Etoposide—muscle cancer	0.00157	0.00157	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Budesonide—Nervous system disorder—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Budesonide—Agitation—Doxorubicin—muscle cancer	0.00155	0.00155	CcSEcCtD
Budesonide—Skin disorder—Methotrexate—muscle cancer	0.00154	0.00154	CcSEcCtD
Budesonide—Hyperhidrosis—Methotrexate—muscle cancer	0.00153	0.00153	CcSEcCtD
Budesonide—Malaise—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Budesonide—Anorexia—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Budesonide—Syncope—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Budesonide—Palpitations—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Budesonide—Loss of consciousness—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Budesonide—Cough—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Budesonide—Insomnia—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Budesonide—Arthralgia—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Budesonide—Paraesthesia—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Budesonide—Dyspnoea—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Budesonide—Somnolence—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—muscle cancer	0.0014	0.0014	CcSEcCtD
Budesonide—Dyspepsia—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Budesonide—Decreased appetite—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Budesonide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Budesonide—Fatigue—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Budesonide—Infection—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Budesonide—Pain—Methotrexate—muscle cancer	0.00136	0.00136	CcSEcCtD
Budesonide—Shock—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Budesonide—Nervous system disorder—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—muscle cancer	0.00134	0.00134	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
Budesonide—Anorexia—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Budesonide—Feeling abnormal—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Budesonide—Gastrointestinal pain—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Budesonide—Urticaria—Methotrexate—muscle cancer	0.00126	0.00126	CcSEcCtD
Budesonide—Abdominal pain—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Budesonide—Body temperature increased—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Budesonide—Insomnia—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Budesonide—Paraesthesia—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Budesonide—Dyspnoea—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Budesonide—Dyspepsia—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Budesonide—Decreased appetite—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Budesonide—Constipation—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Budesonide—Pain—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Budesonide—Hypersensitivity—Methotrexate—muscle cancer	0.00117	0.00117	CcSEcCtD
Budesonide—Asthenia—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Budesonide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Budesonide—Pruritus—Methotrexate—muscle cancer	0.00112	0.00112	CcSEcCtD
Budesonide—Urticaria—Doxorubicin—muscle cancer	0.00109	0.00109	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—muscle cancer	0.00109	0.00109	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—muscle cancer	0.00109	0.00109	CcSEcCtD
Budesonide—Diarrhoea—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Budesonide—Dizziness—Methotrexate—muscle cancer	0.00105	0.00105	CcSEcCtD
Budesonide—Hypersensitivity—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Budesonide—Vomiting—Methotrexate—muscle cancer	0.00101	0.00101	CcSEcCtD
Budesonide—Rash—Methotrexate—muscle cancer	0.001	0.001	CcSEcCtD
Budesonide—Dermatitis—Methotrexate—muscle cancer	0.000999	0.000999	CcSEcCtD
Budesonide—Headache—Methotrexate—muscle cancer	0.000994	0.000994	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—muscle cancer	0.000986	0.000986	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—muscle cancer	0.000972	0.000972	CcSEcCtD
Budesonide—Nausea—Methotrexate—muscle cancer	0.000942	0.000942	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—muscle cancer	0.00094	0.00094	CcSEcCtD
Budesonide—Dizziness—Doxorubicin—muscle cancer	0.000908	0.000908	CcSEcCtD
Budesonide—Vomiting—Doxorubicin—muscle cancer	0.000873	0.000873	CcSEcCtD
Budesonide—Rash—Doxorubicin—muscle cancer	0.000866	0.000866	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—muscle cancer	0.000865	0.000865	CcSEcCtD
Budesonide—Headache—Doxorubicin—muscle cancer	0.000861	0.000861	CcSEcCtD
Budesonide—Nausea—Doxorubicin—muscle cancer	0.000816	0.000816	CcSEcCtD
